References

1. Couroux P, Grosse N, Salapatek AM, Goyal Y, Pfaar O, Hohenfeld IP. Barrier-forming, drug-free nasal spray reduces allergic symptoms induced by house dust mite allergen. Clin Transl Allergy. 2023; e12277. https://doi.org/10.1002/clt2.12277
2. Salapatek AM, Pfaar O, Couroux P, Nehrig J, Grosse N, Hohenfeld I, Fais F, Hohlfeld J, Badorrek P, Sailer M, Koitschev A, Becker S, Meyer T. Efficacy and tolerability of the barrier-forming drug-free nasal spray AM-301 in allergic rhinitis patients exposed to controlled grass pollen and house dust mite challenge. Journal of Allergy and Clinical Immunology. 2023; 151(2): AB108–AB108. https://doi.org/10.1016/j.jaci.2022.12.344
3. Becker S, Deshmukh S, De Looze F, Francardo V, Lee J, McGirr A, Nathan Z, Rook C, Meyer T. AM‐301, a barrier‐forming nasal spray, versus saline spray in seasonal allergic rhinitis: A randomized clinical trial. Allergy. 2024; 79(7): 1858–1867. https://doi.org/10.1111/all.16116
4. Sailer MM, Köllmer M, Masson B, Fais F, Hohenfeld IP, Herbig ME, Koitschev A, Becker S. Nasal residence time and rheological properties of a new bentonite-based thixotropic gel emulsion nasal spray – AM-301. Drug Development and Industrial Pharmacy. 2023; 49(1): 103–114. https://doi.org/10.1080/03639045.2023.2183724